There is an increased emphasis on New Technology Based Finns (NTBFs) and on Strategic Partnerships. The number of strategic partnerships between large, established firms and NTBFs has multiplied over the past few years, due to a growing trend towards technological and marketing relationships between large and small finns. In this contribution, the strategic --predominantly technology -partnering (also referred to as interfirm technology cooperation) experiences of a small number of Belgian NTBFs in the biotechnology and micro-electronics industries will be analysed. The analysis presented here derives from the regionspecific technology policies in Belgium.A multiple case study design was chosen to develop an understanding of the impact of strategic partnering on New Technology ~ased Firm-survival and growth in Belgium. To improve the reliability of conclusions in the research presented here, a small number of cases wiU be investigated for the construction of a theoretical model. Research hypotheses and methodologyA multiple case study design (Yin, 1984; Niederkofler, 1991) was chosen to develop an understanding of the impact of strategic partnering on New Technology Based Firm-survival and growth in Belgium. To improve the reliability of conclusions in the research presented here, multiple cases will be investigated for the construction of a

Purpose: New technology based firm (NTBF) survival and growth are connected with strategic partnering alliances and open innovation within technology clusters. Strategic partnerships in the biotechnology industry allow new technology based firms to gain a foothold in this high-cost, high-risk industry. In this article, we examine the impact of strategic partnerships and open innovation on the success of new biotechnology firms in Belgium by developing multiple case studies of firms in regional biotechnology clusters. A longitudinal follow up of the Belgian biotech startup ecosystem is presented. We find that, despite their small size and relative immaturity, new biotechnology firms are able to adopt innovative business models by providing R&D and services to larger firms and openly cooperating with them through open innovation.Design/methodology/approach: This is a theory-driven paper with suggested theoretical model and case study research design.Originality/value: Although the literature on strategic partnerships is well developed, the majority of studies focus on large, established firms. There is absence of studies that look at strategic partnershipsand specifically the role of open innovationin the development of small and innovative biotechnology firms. This article addresses this gap in the literature with a focus on new firms in the biotechnology cluster in Belgium, where there is a growing trend towards technological and market-driven relationships between large and small biotechnology firms. Practical implications: Our conclusion is that the future of new biotechnology firms in Belgium lies in the effective establishment of strategic partnering alliances. In future research, the impacts of open innovation and novel business models warrant further attention.

This paper summarizes the arguments and counterarguments within the scientific discussion on the healthcare systems’ transformations towards sustainability, considering COVID-19 pandemic. The paper aims to forecast changes in the healthcare sector’s greenhouse gas emissions of the EU countries. For gaining that purpose, the authors carried out the study in the following logical sequence. Firstly, the bibliometric analysis was conducted based on 2313 publications indexed by Scopus database. The study sample consists of 1995 publications indexed by the keywords such as healthcare, green, carbon and sustainable; and 318 publications – green, carbon-free, covid, pandemic, coronavirus and health. The fields for search are titles, keywords and abstracts. The search was limited to the subject areas such as Social science; Environmental sciences; Business, Management and Accounting; Economics, Econometrics and Finance. The time framework is 2000-2020. The scientific background analysis stated the strong relationship between implementing green innovation in the healthcare system towards gaining sustainable development goals. The obtained results indicated that the COVID-19 requires the decisive green transformation in the economy. Thus, the forecast of greenhouse gas volume from the healthcare activity (human health and social work activities; human health activities; manufacture of basic pharmaceutical products and pharmaceutical preparations) until 2030 was conducted. The methodological tool of this research based on the Autoregressive Integrated Moving Average (ARIMA) model. The software EViews 11 was used to provide empirical calculation. This study involved data of the EU countries such as Hungary, Slovakia, Malta, Denmark and Portugal from 1995 to 2019. The base of data is the EU statistical service Eurostat. Based on the obtained results, the authors concluded that there are still disparities in the healthcare sectors of the EU-countries towards sustainability. Therefore, the authors highlighted the necessity to improve the EU countries’ cohesion policy, which would allow decisively and quickly cooperate to find effective solutions towards developing resilience in the healthcare sector due to implementing green strategies. The authors emphasized that this study’s obtained results could be the base for future investigations devoted to effective green solutions to minimize greenhouse gas emissions from the healthcare activity.

No abstract

No abstract